Canadians need safe and legally controlled access to psychedelic drug therapy including psilocybin-assisted therapy which, along with providing treatment for palliative patients, would provide opportunities for research and investment, says Michael Kydd, founder and principal of Kydder Group Inc., in an op-ed.
Organization: Parliament
Feds developing unprecedented long-term research and pandemic preparedness strategy
The federal government is developing Canada’s first long-term research and pandemic preparedness strategy that will include a new Centre for Pandemic Preparedness and Health Emergencies Research. Ottawa has provided nearly $1 million to the Canadian Institutes of Health Research to lead its development.